Insiders Immunome, Inc.

Equities

Market Closed - Nasdaq Other stock markets 21:00:00 13/05/2024 BST			5-day change	1st Jan Change
15.61 ^USD	+0.71%		+0.97%	+45.89%

05-02	Immunome, Inc. Appoints Kinney Horn as Chief Business Officer	CI
04-30	JPMorgan Starts Immunome With Overweight Rating, $24 Price Target	MT

Immunome, Inc. Appoints Kinney Horn as Chief Business Officer	05-02	CI
Immunome, Inc. Appoints Sandra M. Swain to Board of Directors	04-25	CI
Immunome, Inc. Announces Promotion of Max Rosett to Executive Vice President, Operations	02-01	CI
Immunome Appoints Phil Roberts as Chief Technical Officer	01-04	MT
Immunome Appoints Phil Roberts as Chief Technical Officer	01-04	CI
Immunome, Inc. Announces Board Changes	01-02	CI
Immunome, Inc. Announces Executive Changes, Effective January 2, 2024	12-29	CI
Immunome, Inc. Appoints Jean-Jacques Bienaimé to Board of Directors	11-08	CI
Immunome Appoints Bob Lechleider as Chief Medical Officer	19/10/23	CI
Immunome Insider Bought Shares Worth $999,996, According to a Recent SEC Filing	04/10/23	MT
Immunome Insider Bought Shares Worth $249,993, According to a Recent SEC Filing	04/10/23	MT
Immunome, Inc. Announces Formation of Antibody-Drug Conjugate and T Cell Redirection Advisory Board	08/02/23	CI
Insider Buy: Immunome	14/09/21	MT
Insider Buy: Immunome	13/09/21	MT
Immunome, Inc. Announces Executive Changes	05/08/21	CI
Immunome, Inc. Appoints Andrew D. Badley to its COVID-19 Advisory Board	30/06/21	CI
Immunome, Inc. Announces Board Changes	17/06/21	CI
Immunome, Inc. Announces the Appointment of Corleen Roche as Chief Financial Officer	20/04/21	CI
Immunome Appoints Dennis Giesing as Chief Development Officer	30/03/21	CI
Immunome, Inc. Appoints Diane Marcou as Interim Chief Financial Officer	04/12/20	CI

No results for this search